drugset / Trial / NCT01902550

A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants

NCT01902550

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate effect of co-administration of JNJ-54452840 and metoprolol tartrate immediate-release (metoprolol IR) compared to metoprolol IR alone on the exercise heart rate and blood pressure measured at the end of each 3-minute exercise test in healthy participants.

Timeline

Start
2013-07
Primary completion
2013-10
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject MIBENRATIDE Protein / enzyme biologic 240 mg Intravenous
Subject Metoprolol Other / unclassified 100 mg Oral

Indications

No indication recorded.